
Tesarakt
AI for a truly intelligent health system
New York, United States · Founded 2022 · $250K raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- tesarakt.com
- Total Funding
- $250K
- Last Round
- $250K SeedJul 2024
- Rounds
- 1
About
Tesarakt is a Columbia University spin-off developing predictive AI for neurological disease diagnosis. Using machine learning applied to conventional MRI scans and the largest available MRI database, the platform detects Parkinson's and Alzheimer's disease years before first symptoms appear. The company was founded in 2022 and participated in IndieBio NYC Class 4.
Summary
Tesarakt is an Artificial Intelligence company based in New York, United States, founded in 2022. It has raised $250K in total across 1 round, most recently a $250K Seed round in Jul 2024. Investors include IndieBio, SOSV and Ferocity Capital.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2024
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.

xAI is an AI platform for accelerating human scientific discovery.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
